Medication info
Rosadipin Tablet 5/50 mg (Amlodipine, Losartan Potassium)

Rosadipin Tablet 5/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Korea Pavis Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201502663 · Approved 2015.04.30 · Insurance code 621802710

Summary

Main use
Treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this drug (a combination product containing the same strengths of each active ingredient) for convenience. Before administering this drug as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with intravascular volume depletion: Use of this drug is not recommended in a small number of patients with intravascular volume depletion (e.g., patients receiving treatment with high-dose diuretics). (See Section 1, Warnings, in Precautions for Use.) ○ Patients with hepatic impairment: Use of this drug is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: For elderly patients 75 years of age or older, an initial losartan dose of 25 mg once daily is recommended; therefore, use of this drug as initial therapy is not recommended.
Child dose
○ Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Korea Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is a combination of amlodipine and losartan, used in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy. It is also effective for stage 2 hypertension patients who require combination therapy from the outset to reach the therapeutic target blood pressure. In other words, it helps lower blood pressure reliably, reducing the risk of cardiovascular diseases. This medication is used for the treatment of hypertension.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this drug (a combination product containing the same strengths of each active ingredient) for convenience. Before administering this drug as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with intravascular volume depletion: Use of this drug is not recommended in a small number of patients with intravascular volume depletion (e.g., patients receiving treatment with high-dose diuretics). (See Section 1, Warnings, in Precautions for Use.) ○ Patients with hepatic impairment: Use of this drug is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: For elderly patients 75 years of age or older, an initial losartan dose of 25 mg once daily is recommended; therefore, use of this drug as initial therapy is not recommended.

Child dose

○ Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately once pregnancy is confirmed. Taking this medication while pregnant can lead to various problems such as decreased fetal kidney function, low blood pressure, skull formation reduction, and anuria. If it must be taken during early pregnancy, frequent ultrasounds to check the fetus's condition are necessary, and if abnormalities are found, it should be stopped immediately. Administering this medication to patients with a low blood volume may cause hypotension, so stabilization of blood volume should be ensured beforehand. This medication should not be given to patients with allergies to the active ingredients or similar substances, pregnant women or those who may be pregnant, nursing mothers, patients with severe liver dysfunction, severe aortic stenosis, or in a state of shock. Caution should be exercised when administering to patients with low blood volume or strict salt restrictions, moderate to severe kidney impairment, or hyperkalemia. Symptoms such as dizziness and headache may occur during treatment, so dangerous activities such as working at heights or driving should be avoided. This medication lowers blood pressure; therefore, when used in conjunction with other antihypertensive agents, careful attention is needed as the effects may be enhanced. Avoid taking it with grapefruit juice, as it may increase drug concentration and raise the risk of side effects. In clinical trials, side effects such as dizziness, headache, edema, itching, palpitations, orthostatic hypotension, cough, etc. have been reported. Safety has not been established for children, and it is not recommended for patients under 18 years of age. In older adults over 75 years, the initial dose of this drug may not be suitable, requiring careful use. In case of overdose, severe hypotension and tachycardia may occur, and symptoms should be reported to medical personnel immediately. Keep this medication out of reach of children and do not transfer it into another container.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pit edema
Show 176 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • itching
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival hyperemia
  • frequent urination
  • fatigue
  • edema
  • vasculitis
  • increased tension
  • sensory loss
  • paresthesia
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • erythema multiforme-like papular rash
  • heaviness
  • heat sensation
  • decreased glucose tolerance
  • weakness
  • muscle spasms
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • bloating
  • abdominal pain
  • angioedema
  • skin exfoliation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • angina
  • second-degree AV block
  • cerebrovascular accident
  • hypotension
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decline
  • reduced libido
  • memory impairment
  • migraine
  • neural sensitivity
  • panic disorder
  • sleep disturbances
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • nocturia
  • urethral infection
  • low blood pressure
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver dysfunction
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythema
  • hyperkalemia
  • hyponatremia
  • elevated serum creatinine
  • elevated liver enzymes
  • shock symptoms
  • hypotension
  • reflex tachycardia
  • systemic hypotension
  • severe hypotension
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.